Inventor
MELEAN VISNICK
Inventor
US
Overview
Patents· 14 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C07DHeterocyclic compounds20%
A61KPreparations for medical, dental or toiletry purposes18%
C07CAcyclic or carbocyclic compounds11%
C07JSteroids11%
Y02ATechnologies for adaptation to climate change9%
C07BGeneral methods of organic chemistry4%
C07HSugars4%
PatentTitleYear
12,595,278Biaryl amides with modified sugar groups for treatment of diseases associated with heat shock protein pathway202612,545,701C4-modified oleanolic acid derivatives for inhibition of IL-17 and other uses202612,358,866Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17202512,344,631C17 polar-substituted heteroaromatic synthetic triterpenoids and methods of use thereof202512,195,443Pyrimidine tricyclic enone derivatives for inhibition of ROR-gamma and other uses202512,060,340Cysteine-dependent inverse agonists of nuclear receptors ROR-gamma/ROR-gamma-t and methods of treating diseases or disorders therewith202411,993,574Pyrazole and imidazole compounds for inhibition of IL-17 and RORgamma202411,919,838Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17202411,827,664Biaryl amides with modified sugar groups for treatment of diseases associated with heat shock protein pathway202311,814,338Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators202311,584,775C4-modified oleanolic acid derivatives for inhibition of IL-17 and other uses202311,406,648C17-heteroaryl derivatives of oleanolic acid and methods of use thereof202211,292,781Pyrimidine tricyclic enone derivatives for inhibition of ROR-gamma and other uses202211,192,852Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2026Patents assigned to REATA PHARMACEUTICALS INC (12)· patent assignee history
2021–2026Based in US· patent location history
2024–2025Patents assigned to REATA PHARMACEUTICALS HOLDINGS LLC (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| REATA PHARMACEUTICALS INC | 12 | 2021–2026 |
| REATA PHARMACEUTICALS HOLDINGS LLC | 2 | 2024–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 14 | 2021–2026 |